Compare GBIO & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBIO | HQI |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 111.0M |
| IPO Year | 2020 | N/A |
| Metric | GBIO | HQI |
|---|---|---|
| Price | $5.49 | $9.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $8.88 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 58.5K | 48.4K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ 412.84 |
| EPS | N/A | ★ 0.50 |
| Revenue | $15,270,000.00 | ★ $31,691,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.87 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.00 | $7.38 |
| 52 Week High | $12.50 | $15.75 |
| Indicator | GBIO | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 59.74 |
| Support Level | $5.20 | $7.38 |
| Resistance Level | $5.70 | $8.91 |
| Average True Range (ATR) | 0.24 | 0.58 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 72.11 | 86.73 |
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.